Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Up 1,700.0% in November

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,800 shares, an increase of 1,700.0% from the October 31st total of 100 shares. Based on an average trading volume of 19,600 shares, the days-to-cover ratio is currently 0.1 days.

Fortress Biotech Price Performance

FBIOP stock opened at $5.20 on Friday. Fortress Biotech has a twelve month low of $4.86 and a twelve month high of $18.00. The company’s 50 day moving average is $5.35 and its two-hundred day moving average is $9.03.

About Fortress Biotech

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.